Imaging Plaques to Predict and Better Manage Patients With Acute Coronary Events

Culprit lesions of patients, who have had an acute coronary syndrome commonly, are ruptured coronary plaques with superimposed thrombus. The precursor of such lesions is an inflamed thin-capped fibroatheroma. These plaques can be imaged by means of invasive techniques, such as intravascular ultrasound (and derived techniques), optical coherence tomography, and near-infrared spectroscopy. Often these patients exhibit similar (multiple) plaques beyond the culprit lesion. These remote plaques can be assessed noninvasively by computed tomographic angiography and MRI and also using invasive imaging. The detection of these remote plaques is not only feasible but also in natural history studies have been associated with clinical coronary events. Different systemic pharmacological treatments have been studied (mostly statins) with modest success and, therefore, newer approaches are being tested. Local treatment for such lesions is in its infancy and larger, prospective, and randomized trials are needed. This review will describe the pathological and imaging findings in culprit lesions of patients with acute coronary syndrome and the assessment of remote plaques. In addition, the pharmacological and local treatment options will be reviewed.

[1]  Hiroshi Takahashi,et al.  Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. , 2010, Clinical therapeutics.

[2]  Samin K. Sharma,et al.  Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy). , 2013, Journal of the American College of Cardiology.

[3]  Jean-Claude Tardif,et al.  In vivo validation of a catheter-based near-infrared spectroscopy system for detection of lipid core coronary plaques: initial results of the SPECTACL study. , 2009, JACC. Cardiovascular imaging.

[4]  S. Nissen Halting the progression of atherosclerosis with intensive lipid lowering: results from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. , 2005, The American journal of medicine.

[5]  R. Virmani,et al.  Culprit plaque in myocardial infarction going beyond angiography. , 2007, Journal of the American College of Cardiology.

[6]  James E. Muller,et al.  Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. , 2008, JACC. Cardiovascular imaging.

[7]  Peter Libby,et al.  Effect of two intensive statin regimens on progression of coronary disease. , 2011, The New England journal of medicine.

[8]  Jean-Claude Tardif,et al.  Effect of torcetrapib on the progression of coronary atherosclerosis. , 2007, The New England journal of medicine.

[9]  J. Deckers,et al.  Long-term effect of perindopril on coronary atherosclerosis progression (from the perindopril's prospective effect on coronary atherosclerosis by angiography and intravascular ultrasound evaluation [PERSPECTIVE] study). , 2007, The American journal of cardiology.

[10]  René M. Botnar,et al.  Serial contrast-enhanced cardiac magnetic resonance imaging demonstrates regression of hyperenhancement within the coronary artery wall in patients after acute myocardial infarction. , 2009, JACC. Cardiovascular imaging.

[11]  K. Node,et al.  High-intensity signals in coronary plaques on noncontrast T1-weighted magnetic resonance imaging as a novel determinant of coronary events. , 2014, Journal of the American College of Cardiology.

[12]  Akiko Maehara,et al.  Clinical and angiographic characteristics of patients likely to have vulnerable plaques: analysis from the PROSPECT study. , 2013, JACC. Cardiovascular imaging.

[13]  Zahi A. Fayad,et al.  Imaging of atherosclerotic cardiovascular disease , 2008, Nature.

[14]  C. Yuan,et al.  Accuracy of MRI to identify the coronary artery plaque: A comparative study with intravascular ultrasound , 2012, Journal of magnetic resonance imaging : JMRI.

[15]  A. Yeung,et al.  Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. , 2001, Journal of the American College of Cardiology.

[16]  Frits Mastik,et al.  Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque , 2008, Circulation.

[17]  Raimund Erbel,et al.  Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. , 2006, JAMA.

[18]  E. Tuzcu,et al.  Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. , 2008, JAMA.

[19]  Colin Berry,et al.  Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial. , 2007, JAMA.

[20]  J. Lindsay,et al.  Predictors of coronary arterial remodeling patterns in patients with myocardial ischemia. , 1997, The American journal of cardiology.

[21]  Antonio Colombo,et al.  Intravascular Ultrasound Assessment of Ulcerated Ruptured Plaques: A Comparison of Culprit and Nonculprit Lesions of Patients With Acute Coronary Syndromes and Lesions in Patients Without Acute Coronary Syndromes , 2003, Circulation.

[22]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[23]  Carl J Pepine,et al.  Effect of ACAT inhibition on the progression of coronary atherosclerosis. , 2006, The New England journal of medicine.

[24]  Byeong Ha Lee,et al.  Combined system of optical coherence tomography and fluorescence spectroscopy based on double-cladding fiber. , 2008, Optics letters.

[25]  Yen-Hung Lin,et al.  The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[26]  Y. Neishi,et al.  Measurement of the thickness of the fibrous cap by optical coherence tomography. , 2006, American heart journal.

[27]  M. Caulfield,et al.  Effects of torcetrapib in patients at high risk for coronary events. , 2007, The New England journal of medicine.

[28]  Diane M. Miller,et al.  Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in Diabetes Patients With Cardiovascular History Trial , 2010, Circulation.

[29]  Z. Fayad,et al.  Effect of treatment for 12 weeks with rilapladib, a lipoprotein-associated phospholipase A2 inhibitor, on arterial inflammation as assessed with 18F-fluorodeoxyglucose-positron emission tomography imaging. , 2014, Journal of the American College of Cardiology.

[30]  Paul Schoenhagen,et al.  Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. , 2003, JAMA.

[31]  C. Cogbill,et al.  Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? , 2003, Journal of the American College of Cardiology.

[32]  Jagat Narula,et al.  The popcorn plaques , 2007, Nature Medicine.

[33]  Pai-Chi Li,et al.  Integrated intravascular ultrasound and photoacoustic imaging scan head. , 2010, Optics letters.

[34]  M. Szklo,et al.  MRI detects increased coronary wall thickness in asymptomatic individuals: The multi‐ethnic study of atherosclerosis (MESA) , 2008, Journal of magnetic resonance imaging : JMRI.

[35]  Pankaj Garg,et al.  Arithmetic of vulnerable plaques for noninvasive imaging , 2008, Nature Clinical Practice Cardiovascular Medicine.

[36]  P. Serruys,et al.  Coronary plaque composition of nonculprit lesions, assessed by in vivo intracoronary ultrasound radio frequency data analysis, is related to clinical presentation. , 2006, American heart journal.

[37]  Eric J Topol,et al.  Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. , 2004, JAMA.

[38]  P. Pais,et al.  Darapladib for preventing ischemic events in stable coronary heart disease. , 2014, The New England journal of medicine.

[39]  A. Jeremias,et al.  Coronary artery compliance and adaptive vessel remodelling in patients with stable and unstable coronary artery disease , 2000, Heart.

[40]  R. Virmani,et al.  Frequency and distribution of thin-cap fibroatheroma and ruptured plaques in human coronary arteries: a pathologic study. , 2007, Journal of the American College of Cardiology.

[41]  H. Sillesen,et al.  Molecular pathology in vulnerable carotid plaques: correlation with [18]-fluorodeoxyglucose positron emission tomography (FDG-PET). , 2009, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[42]  T. Akasaka,et al.  Feasibility of noninvasive assessment of thin-cap fibroatheroma by multidetector computed tomography. , 2009, JACC. Cardiovascular imaging.

[43]  Patrick W Serruys,et al.  Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[44]  Hirofumi Anno,et al.  Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. , 2007, Journal of the American College of Cardiology.

[45]  Ahmed Tawakol,et al.  Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina. , 2010, JACC. Cardiovascular imaging.

[46]  D. Glogar,et al.  Intravascular ultrasound predictors of major adverse cardiac events in patients with unstable angina , 2000, Clinical cardiology.

[47]  Evelyn Regar,et al.  In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. , 2014, European heart journal.

[48]  Stanislav Y. Emelianov,et al.  Development of a catheter for combined intravascular ultrasound and photoacoustic imaging. , 2010, The Review of scientific instruments.

[49]  Ahmed Tawakol,et al.  Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial , 2011, The Lancet.

[50]  Bo Yu,et al.  In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. , 2013, Journal of the American College of Cardiology.

[51]  C von Birgelen,et al.  Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. , 2001, Journal of the American College of Cardiology.

[52]  B. Bouma,et al.  Association of statin therapy with reduced coronary plaque rupture: an optical coherence tomography study , 2008, Coronary artery disease.

[53]  S. Achenbach,et al.  Noninvasive assessment of plaque morphology and composition in culprit and stable lesions in acute coronary syndrome and stable lesions in stable angina by multidetector computed tomography. , 2006, Journal of the American College of Cardiology.

[54]  Takashi Akasaka,et al.  The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound. , 2010, JACC. Cardiovascular interventions.

[55]  J. Kastelein,et al.  Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial. , 2014, JAMA.

[56]  Zahi A. Fayad,et al.  Perspectives and opportunities for nanomedicine in the management of atherosclerosis , 2011, Nature Reviews Drug Discovery.

[57]  H. Fujita,et al.  Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. , 2005, Journal of the American College of Cardiology.

[58]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[59]  V. Fuster,et al.  Histopathologic characteristics of atherosclerotic coronary disease and implications of the findings for the invasive and noninvasive detection of vulnerable plaques. , 2013, Journal of the American College of Cardiology.

[60]  Renu Virmani,et al.  Vulnerable plaque: the pathology of unstable coronary lesions. , 2002, Journal of interventional cardiology.

[61]  D. Vince,et al.  Automated coronary plaque characterisation with intravascular ultrasound backscatter: ex vivo validation. , 2007, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[62]  M Valgimigli,et al.  Coronary artery remodelling is related to plaque composition , 2005, Heart.

[63]  P. Libby Inflammation in atherosclerosis , 2002, Nature.

[64]  Brett E Bouma,et al.  Measurement of collagen and smooth muscle cell content in atherosclerotic plaques using polarization-sensitive optical coherence tomography. , 2007, Journal of the American College of Cardiology.

[65]  C. Rochitte,et al.  Regression of coronary artery outward remodeling in patients with non-ST-segment acute coronary syndromes: a longitudinal study using noninvasive magnetic resonance imaging. , 2006, American heart journal.

[66]  R. Virmani,et al.  Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. , 2011, European heart journal.

[67]  R. Virmani,et al.  Concept of vulnerable/unstable plaque. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[68]  A. Yeung,et al.  The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. , 1995, The New England journal of medicine.

[69]  René M. Botnar,et al.  Visualization of Coronary Wall Atherosclerosis in Asymptomatic Subjects and Patients with Coronary Artery Disease Using Magnetic Resonance Imaging , 2010, PloS one.

[70]  Akiko Maehara,et al.  Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. , 2002, Journal of the American College of Cardiology.

[71]  V. Fuster,et al.  OCT-based diagnosis and management of STEMI associated with intact fibrous cap. , 2013, JACC. Cardiovascular imaging.

[72]  M. Dweck,et al.  18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial , 2014, The Lancet.

[73]  G. Pasterkamp,et al.  Multiple complex coronary plaques in patients with acute myocardial infarction. , 2001, The New England journal of medicine.

[74]  Masatoshi Ishibashi,et al.  Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. , 2006, Journal of the American College of Cardiology.

[75]  V. Fuster,et al.  2-deoxy-2-[18F]fluoro-d-mannose positron emission tomography imaging in atherosclerosis , 2014, Nature Medicine.

[76]  Michail I. Papafaklis,et al.  Prediction of Progression of Coronary Artery Disease and Clinical Outcomes Using Vascular Profiling of Endothelial Shear Stress and Arterial Plaque Characteristics: The PREDICTION Study , 2012, Circulation.

[77]  Yoram Rudy,et al.  From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. , 2006, The American journal of cardiology.

[78]  Takashi Akasaka,et al.  Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. , 2007, Journal of the American College of Cardiology.

[79]  M. McConnell,et al.  Noninvasive assessment of coronary vasodilation using cardiovascular magnetic resonance in patients at high risk for coronary artery disease , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.

[80]  D. Berman,et al.  Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemia. , 2014, JACC. Cardiovascular interventions.

[81]  Takashi Akasaka,et al.  Effect of statin therapy on coronary fibrous-cap thickness in patients with acute coronary syndrome: assessment by optical coherence tomography study. , 2009, Atherosclerosis.

[82]  Gary S Mintz,et al.  Intravascular Ultrasound Analysis of Infarct‐Related and Non‐Infarct‐Related Arteries in Patients Who Presented With an Acute Myocardial Infarction , 2003, Circulation.

[83]  J. H. Rudd,et al.  Effects of p38 mitogen-activated protein kinase inhibition on vascular and systemic inflammation in patients with atherosclerosis. , 2012, JACC. Cardiovascular imaging.

[84]  P. Joshi,et al.  Coronary atherosclerosis imaging by coronary CT angiography: current status, correlation with intravascular interrogation and meta-analysis. , 2011, JACC. Cardiovascular imaging.

[85]  M. Bennett,et al.  Association between IVUS findings and adverse outcomes in patients with coronary artery disease: the VIVA (VH-IVUS in Vulnerable Atherosclerosis) Study. , 2011, JACC. Cardiovascular imaging.

[86]  René M. Botnar,et al.  Selective coronary artery plaque visualization and differentiation by contrast-enhanced inversion prepared MRI. , 2006, European heart journal.

[87]  R. Virmani,et al.  Clinical Feasibility of Molecular Imaging of Plaque Inflammation in Atherosclerosis , 2009, Journal of Nuclear Medicine.